Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marie-France Mamzer1, Sophie Dubois2, Christian Saout3

  • 1Laboratory of medical ethics, university Paris Descartes EA 4569, functional unit of medical ethics, Neckers children's hospital, AP-HP, 75015 Paris, France.

Therapie
|February 27, 2018
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunological efficacy and safety of influenza vaccination in adults with sarcoidosis: the SARCOVAC study.

Vaccine·2026
Same author

Ten years of European International Intensive Infectious Disease Courses (I3DC/IDEAL): long-term impact for undergraduate medical students.

BMC medical education·2026
Same author

Building a Robust Investigator-Initiated Platform: The I-CARE Experience.

Clinical pharmacology and therapeutics·2026
Same author

Therapie·2026
Same author

How to differentiate between clinical added value (CAV) V drugs: What are the implications, and what is the access pathway?

Therapie·2026
Same author

The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs.

Journal of multidisciplinary healthcare·2025
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles
This summary is machine-generated.

Patient involvement in health technology assessments (HTA) is crucial for healthcare democracy but lacks standardized methods. This study focuses on developing national recommendations for patient engagement in HTA processes in France.

Area of Science:

  • Health Technology Assessment
  • Healthcare Policy
  • Patient Engagement

Background:

  • Rising healthcare costs and technological advancements necessitate careful decisions on new technology adoption and funding.
  • Patient participation in healthcare decision-making is a key goal for healthcare democracy.
  • International patient involvement in health technology assessments (HTA) is growing but lacks standardized terminology and methods.

Purpose of the Study:

  • To address the variability in patient and public involvement in HTA.
  • To develop national recommendations for patient involvement in HTA processes in France.
  • To focus on HTA for medicinal products and medical devices.

Main Methods:

  • Analysis of existing patient involvement strategies in HTA.
Keywords:
Health product assessmentHealth technology assessment (HTA)Healthcare democracyPatient evidencePatient involvement

Related Experiment Videos

  • Focus on patient insight collection (experiences, needs, preferences).
  • Examination of processes for including patients in assessments (individual and representative capacities).

    • Main Results:

    • Patient involvement in HTA is diverse, ranging from insight collection to direct participation.
    • Significant variation exists in patient involvement across countries, fields, and technology types.
    • The complexity of health technologies poses challenges to comprehensive patient understanding.

    Conclusions:

    • Standardized approaches are needed to effectively integrate patient perspectives into HTA.
    • Developing national recommendations is essential for consistent and meaningful patient involvement in French HTA.
    • Further research and consensus-building are required to refine patient involvement methodologies in HTA.